Exclusive

Publication

Byline

Location

Clinical Trial: TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740499) titled 'TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Dise... Read More


Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, mu... Read More


Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab ... Read More


Clinical Trial: Human-Created vs AI-generated Art on Immediate Psychological Responses

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740148) titled 'Human-Created vs AI-generated Art on Immediate Psychological Responses' on July 28. Brief S... Read More


Clinical Trial: Comparative Effects of ESP Block and EOIP Block on Postoperative Respiratory Recovery Following Liver Resection

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740382) titled 'Comparative Effects of ESP Block and EOIP Block on Postoperative Respiratory Recovery Follow... Read More


Clinical Trial: Diagnosis of Hidden Hearing Loss in Adults : Refining the Audiological Profile for Better Diagnosis.

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738549) titled 'Diagnosis of Hidden Hearing Loss in Adults : Refining the Audiological Profile for Better Di... Read More


Clinical Trial: Routine LDL Exam For Cancer Survivors

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738250) titled 'Routine LDL Exam For Cancer Survivors' on July 26. Brief Summary: This observational study ... Read More


Clinical Trial: A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA(R) (Levonorgestrel and Ethinyl Estradiol) Transdermal System

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739589) titled 'A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradi... Read More


Clinical Trial: Iron Status Assessment in Geriatric Elderly

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739524) titled 'Iron Status Assessment in Geriatric Elderly' on July 28. Brief Summary: In elderly adults, ... Read More


Clinical Trial: The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739160) titled 'The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients' on July 28. Brief Su... Read More